Robert Ball, DO
Interventional Pain Medicine · Port Charlotte, FLNPI 1841454477
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $195,921 of the $246,486 with a category attached, or 79.5%. 30 manufacturers reported payments, led by Relievant Medsystems, Inc. at 54.6% of the total. Among interventional pain medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 600 payments — averaging $410.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Relievant Medsystems, Inc.$135K
- Boston Scientific$97K
- Abbott$6K
- Foundation Fusion Solutions, LLC$2K
- Medtronic$1K
- Nevro Corp.$1K
- plus $4K from 24 others
Across 30 payments — averaging $1199.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$21K
- Relievant Medsystems, Inc.$9K
- Nalu Medical, Inc.$4K
- Vertiflex, Inc.$1K
What the payments were for
- Consulting fees$15,2636%
- Speaking & faculty fees$195,92179%
- Travel & lodging$16,0196%
- Food & beverage$18,9738%
- Entertainment$3110%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Relievant Medsystems, Inc. | 195 | $134,688 |
| Boston Scientific | 200 | $96,975 |
| Abbott | 43 | $6,250 |
| Foundation Fusion Solutions, LLC | 24 | $2,257 |
| Medtronic(2 entities) | 21 | $1,345 |
| Nevro Corp. | 21 | $1,078 |
| Painteq LLC | 17 | $738 |
| Nalu Medical, Inc. | 8 | $444 |
| Vertos Medical, Inc. | 5 | $406 |
| VGI Medical, LLC | 3 | $387 |
| AbbVie(2 entities) | 19 | $386 |
| Vertiflex, Inc. | 6 | $326 |
| MML US, Inc. | 8 | $288 |
| Stryker | 2 | $214 |
| Stimwave Technologies Incorporated | 1 | $164 |
| Curonix LLC | 3 | $72 |
| Lundbeck LLC | 3 | $68 |
| SPR Therapeutics, Inc | 3 | $66 |
| Si-bone, Inc. | 3 | $61 |
| Merit Medical Systems Inc | 2 | $53 |
| Almatica Pharma LLC | 2 | $32 |
| Fidia Pharma USA Inc. | 2 | $29 |
| Averitas Pharma Inc. | 1 | $26 |
| Biotronik NRO, Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 2 | $23 |
| Globus Medical | 1 | $23 |
| Pacira Therapeutics, Inc. | 1 | $22 |
| Spinal Simplicity, LLC | 1 | $19 |
| Avanos Medical | 1 | $14 |
| Saluda Medical Americas, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$480,998
- WaveWriter Alpha Prime 16$7,112
- Neuromodulation Dspsbls and Accs$3,850
- PROCLAIM$1,271
- Senza$401
- OSTEOCOOL RF ABLATION$398
- mild Device Kit$377
- SiJoin$334
- Nalu Neurostimulation System$325
- PAINTEQ$301
- VANTA ADAPTIVESTIM$289
- Senza Spinal Cord Stimulation System$264
- Superion ISS$216
- IVS - VERTEBRAL AUGMENTATION PRODUCTS$189
- Proclaim Family of SCS IPGs$141
- Protege Family of SCS IPGs$134
- KYPHON Balloon Kyphoplasty$130
- ReActiv8$128
- GENERAL PAIN MANAGEMENT$121
How this compares
$246,486 in reported general payments places this provider in the 95th percentile of 278 interventional pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BotoxOnabotulinumtoxina | 20 | $25,669 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,041 | $20,502 |
| Buprenorphine | 61 | $15,513 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 471 | $12,998 |
| BelbucaBuprenorphine Hcl | 11 | $10,716 |
| Tramadol Hcl | 972 | $7,634 |
| Pregabalin | 252 | $5,771 |
| Gabapentin | 250 | $3,720 |
| Tramadol Hcl ErTramadol Hcl | 19 | $1,568 |
| Oxycodone Hcl | 67 | $1,369 |
| Methylprednisolone | 151 | $980 |
| Duloxetine Hcl | 64 | $643 |
| Celecoxib | 22 | $470 |
| Cephalexin | 114 | $467 |
| Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen | 24 | $405 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieBotox | $386 | $25,66920 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 278 interventional pain medicine providers in Florida.
Other interventional pain medicine in Port Charlotte
- Lee JamesPort Charlotte$40K
- Louis RasoJupiter$1.3M
- Ajay AntonyGainesville$1.1M
- Michael EspositoVero Beach$777K
- Nomen AzeemRiverview$650K
- Stanley GolovacMerritt Island$367K
- Sunil PanchalLutz$363K
- Justin MannJacksonville$243K
- Giuseppe PaeseBoca Raton$180K
- Miguel de la GarzaNew Port Richey$138K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.